−£33k
vs Mar 2024Active11268910Private limited companyCroydon
GENEALFA LIMITED
Significant control: Alexandra King (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Genealfa Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Genealfa Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
GENEALFA LIMITED is an active private limited company (company number 11268910) incorporated on 22 March 2018, registered in Croydon. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 31 March 2025, showing net assets of −£33k, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 54% on the prior period (−£72k).
Peer position · net assets
By net assets it sits in the bottom quarter of 151 comparable companies in Greater London (median £200, upper quartile £53k).
02
Ownership and control
- Ms Alexandra King
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 22 March 20188 yrs ago
- Next accounts due
- 31 December 2026in 66 days
- Confirmation statement due
- 5 April 2027in 161 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- SIC 74909
- Other professional, scientific and technical activities n.e.c.
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
05
Financials
Not reported
Not disclosed
1
No changevs Mar 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2025 | −£33k | — | — | £183k | — | — | 1 |
| 31 March 2024 | −£72k | — | — | £220k | — | — | 1 |
Current ratio0.81Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
06
Filing and accounts signals
- Net assets below zeroNet assets £-33,234 at 31 March 2025
- Net assets up 10% or more on the prior period+53.9% vs prior period
- Current assets below creditors within one yearCurrent ratio 0.81
- Incorporated five or more years agoIncorporated 22 March 2018
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 161 days
- Next accounts duein 66 days
- Accounts period endNet liabilities £33k · micro accounts
- Accounts period endNet liabilities £72k · micro accounts
- Incorporated
08
Similar companies in Greater London
- SMCGSTAT LTDUxbridge · inc. Apr 2018
- AQBIO LIMITEDRichmond · inc. Mar 2018
- ADVANCED CELL TECHNOLOGIES LTDBarnet · inc. Feb 2018
- NEOHAIR LTDWest Drayton · inc. Apr 2018
- ETHERICA LTDCroydon · inc. Jan 2018
- DR GARY MOORE CONSULTING LIMITEDBexley · inc. Jan 2018
All companies incorporated on 22 March 2018 · in Mar 2018.
09
Reminders for GENEALFA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.